The Wegovy Golden Dose Amount: Separating the Myth from the Medicine

The biggest myth: there's one magic amount that works for everyone

Spend ten minutes on a weight-loss forum and you'll find confident posts declaring that 1.7mg is "the sweet spot" or that 2.4mg is where results really start. The instinct to identify a single golden number is understandable, but it sits awkwardly with how semaglutide actually works.

Wegovy's titration schedule exists because the drug's GI side effects are dose-dependent. Moving too fast causes more nausea, vomiting and disruption; moving through the schedule at roughly four-week intervals lets most people's systems adjust before the next step. The doses aren't rungs on a ladder you climb until you hit a magic level, they're a structured protocol designed to get you to the therapeutic maintenance dose with the least unnecessary discomfort.

What forum posts call the "golden dose" is usually someone's honest personal experience: their appetite fell sharply at 1.7mg, or they didn't tolerate 2.4mg well, and they stayed at the lower level with good results. That's a legitimate clinical outcome. It's not a discovery about semaglutide pharmacology, it's an individual response, and if you want to understand what the Wegovy golden dose concept actually means, your own experience may differ entirely from what you read online. The full Wegovy dose range explains what each stage is designed to achieve.

The STEP 1 trial, published in the New England Journal of Medicine, reported an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose. That average emerged from participants who completed the full titration, not those who stopped at an intermediate stage. Individual variation around that average was substantial.

What the licensed schedule actually looks like, and why the ceiling just got higher

If you want a clear picture of the specific Wegovy dosage amounts used at each stage, the titration follows five steps: 0.25mg for four weeks, then 0.5mg, 1.0mg, 1.7mg, and finally 2.4mg as the standard maintenance dose. Each step lasts approximately four weeks; the pace is guided by your prescriber based on how you're tolerating treatment. The pen lives in the fridge between uses, a detail that catches some people out when they're first prescribed it, always check the storage section of your patient information leaflet rather than relying on a general guide for the precise room-temperature window.

Since January 2026 the picture has changed. The MHRA approved a 7.2mg weekly maintenance dose (initially delivered as three 2.4mg pens) and on 14 April 2026 approved a dedicated single-dose 7.2mg pen for adults with a BMI of 30 or above. Trials at this higher dose reported average weight loss of around 20.7% over 72 weeks, narrowing the gap with tirzepatide's results at its highest dose. If you're wondering whether this higher amount might apply to you, that's a conversation for a prescriber, not a forum. You can read more about the Wegovy dose progression if you want a clear breakdown of the schedule.

None of this changes the core principle: dose decisions sit with a clinician. The NHS medicines page on semaglutide sets out what each strength is and who adjusts it, worth reading alongside your patient leaflet.

If your weight loss stalls at an intermediate dose, is staying there the right call?

This is probably the question underneath most "golden dose" searches. The short answer is: it depends, and your prescriber needs to be involved in that decision.

NICE's guidance on semaglutide (Wegovy) recommends considering whether to continue treatment if less than 5% weight loss has occurred after six months at the maintenance dose. That threshold is built around the full 2.4mg level, not an intermediate one. Staying at 1.7mg long-term because it suits you better is a clinical decision, not a personal preference call, your prescriber weighs your response, any side effects, and your overall health before recommending it.

What doesn't make sense is choosing an amount based on what worked for someone else online, or staying at a lower dose to cut costs. If you're finding the standard schedule difficult or have questions about whether a different amount might suit you better, the right route is to raise it in a clinical review. Our guide on how to use the golden dose concept covers this in more detail, and our overview of whether a golden dose actually exists addresses the broader question head-on.

Cost is occasionally cited as a reason people prefer a lower dose. If that's a factor for you, the transparent pricing page on weight-loss treatments at nume sets out what's included, one price, no hidden prescription or delivery fees, clinical re-review before every repeat. Worth understanding before adjusting your dose for financial reasons rather than clinical ones.

How a prescriber actually decides your dose amount

At every repeat, a GPhC-registered prescriber reviews your case afresh. They're looking at the weight you've recorded, any side effects you've reported, how long you've been at your current dose, and whether titrating up is appropriate. The decision to move from 1.7mg to 2.4mg (or to hold, or to discuss the 7.2mg option) isn't algorithmic.

This is worth stating plainly because some online services send the next dose automatically without meaningful clinical review. That approach worries our prescribers. A real clinical review before each repeat isn't box-ticking; it's what catches the person whose nausea has become severe, or who has developed a condition that changes their treatment plan. Our clinical team reviews every order personally, same day.

If you're considering starting Wegovy or have questions about where you are in the titration, check your eligibility with our prescribers, the consultation is free and reviewed the same day.